UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
____________________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
report (Date of earliest event reported): April 1, 2010
Emergent
BioSolutions Inc.
(Exact
Name of Registrant as Specified in Charter)
Delaware
|
001-33137
|
14-1902018
|
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
2273
Research Boulevard, Suite 400, Rockville, Maryland
|
20850
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (301) 795-1800
Not
applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item
1.01. Entry into a Material Definitive Agreement.
On April
1, 2010, Emergent BioSolutions Inc. (the “Company”) entered into a consulting
services agreement with The Hauer Group under which The Hauer Group provides
strategic consulting and domestic and international marketing advice to the
Company. The consulting services agreement is effective as of April 1, 2010 and
replaces a prior agreement between the Company and The Hauer Group for similar
services that expired on April 1, 2010. Jerome Hauer, a member of the Company’s
Board of Directors, is the chief executive officer of The Hauer Group, and Mr.
Hauer and his wife are the sole owners of The Hauer Group. Under the terms of
the agreement, the Company agreed to pay the Hauer Group $15,000 per month for
its services and reimburse The Hauer Group for reasonable out-of-pocket
expenses. The agreement expires on April 1, 2011, unless extended by mutual
agreement.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: April
7, 2010
|
EMERGENT
BIOSOLUTIONS INC.
|
|
By:
|
/s/ Jay
G. Reilly
Jay
G. Reilly
Acting
General Counsel
|